Brainsway (BRSYF) Share-based Compensation (2018 - 2026)
Brainsway's (BRSYF) quarterly Share-based Compensation came in at $667000.0 in Q2 2026, up 193.83% on a YoY basis from $227000.0 in Q2 2025, and up 95.03% quarter-over-quarter from $342000.0 in Q1 2026.
Powered by 
Analysis
Brainsway (BRSYF) Share-based Compensation (2018 - 2026) Analysis & Trends
Brainsway (BRSYF) has reported Share-based Compensation for 9 consecutive years, with $667000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation rose 193.83% year-over-year to $667000.0; the trailing twelve-month figure through Jun 2026 stood at $1.9 million (down 69.9% YoY), and the FY2025 full-year result was $1.2 million, down 78.42% from the prior year.
- Share-based Compensation improved to $667000.0 in Q2 2026 per BRSYF's latest filing, from $342000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $5.5 million in Q3 2024 and bottomed at -$51000.0 in Q1 2023.
- Historically, Share-based Compensation has averaged $603166.7 across 5 years, with a median of $340500.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Share-based Compensation plunged 113.64% in 2023, then surged 5656.84% in 2024.
- Over 5 years, Share-based Compensation stood at $353000.0 in 2022, then sank by 33.71% to $234000.0 in 2023, then jumped by 64.1% to $384000.0 in 2024, then slipped by 26.82% to $281000.0 in 2025, then soared by 137.37% to $667000.0 in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $667000.0, $342000.0, and $281000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.71 Bn | 174.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 128.01 Bn | 122.80 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.20 Bn | 108.38 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 104.00 Bn | 100.53 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.32 Bn | 62.78 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.70 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.88 Bn | 31.43 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.27 Bn | 30.33 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | 667,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 667,000.00 |
| Mar 31, 2026 | 342,000.00 |
| Dec 31, 2025 | 281,000.00 |
| Sep 30, 2025 | 638,000.00 |
| Jun 30, 2025 | 227,000.00 |
| Mar 31, 2025 | 325,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 5.47 Mn |
| Jun 30, 2024 | 364,000.00 |
| Mar 31, 2024 | 305,000.00 |
| Dec 31, 2023 | 234,000.00 |
| Sep 30, 2023 | 95,000.00 |
| Jun 30, 2023 | 103,000.00 |
| Mar 31, 2023 | -51,000.00 |
| Dec 31, 2022 | 353,000.00 |
| Sep 30, 2022 | 339,000.00 |
| Jun 30, 2022 | 408,000.00 |
| Mar 31, 2022 | 374,000.00 |
| Dec 31, 2021 | 416,000.00 |
| Sep 30, 2021 | 394,000.00 |